Article Versions Notes

Povey JF, Saintas E, Aderemi AV, Rothweiler F, Zehner R, Dirks WG, Cinatl J Jr., Racher AJ, Wass MN, Smales CM, et al. Intact-Cell MALDI-ToF Mass Spectrometry for the Authentication of Drug-Adapted Cancer Cell Lines. Cells. 2019; 8(10):1194. https://doi.org/10.3390/cells8101194

Povey, Jane F., Emily Saintas, Adewale V. Aderemi, Florian Rothweiler, Richard Zehner, Wilhelm G. Dirks, Jindrich Cinatl, Jr., Andrew J. Racher, Mark N. Wass, C. Mark Smales, and et al. 2019. "Intact-Cell MALDI-ToF Mass Spectrometry for the Authentication of Drug-Adapted Cancer Cell Lines" Cells 8, no. 10: 1194. https://doi.org/10.3390/cells8101194

Povey, J. F., Saintas, E., Aderemi, A. V., Rothweiler, F., Zehner, R., Dirks, W. G., Cinatl, J., Jr., Racher, A. J., Wass, M. N., Smales, C. M., & Michaelis, M. (2019). Intact-Cell MALDI-ToF Mass Spectrometry for the Authentication of Drug-Adapted Cancer Cell Lines. Cells, 8(10), 1194. https://doi.org/10.3390/cells8101194